PharmiWeb2h
7 Key Steps for Ensuring Responsible AI Use in Recruitment
The integration of AI in life science recruitment is already reshaping hiring processes by offering increased efficiency, ...
PharmiWeb7m
Great Place To Work and Fortune Name Chiesi Group No. 23 in 2024 World’s Best Workplaces™ List
Chiesi Group, an international biopharmaceutical company focused on research, has been named one of the 25 World’s Best Workplaces™ in 2024 by Great Place To Work® (GPTW) and Fortune magazine, ranking ...
PharmiWeb15h
AC Immune Reports Positive Interim Results from Phase 2 Trial of ACI-7104.056 Active Immunotherapy in Early Parkinson’s Disease
Active immunotherapy with ACI-7104.056 induces high anti-a-synuclein antibody levels on average 16-fold higher than placebo after 3 immunizations 100% of patients receiving ACI-7104.056 responded ...
PharmiWeb15h
SEKISUI Completes £15.7 Million Expansion in cGMP Biopharma CDMO Capacity
Burlington, MA, USA – November 14, 2024 –SEKISUI Diagnostics’ microbial CDMO business announces it has completed construction of its £15.7 million ($20.7 million) cGMP capacity expansion at its UK ...
PharmiWeb1h
Cellev8 Nutrition Inc (Formerly Preferred Commerce) Clarifies Business Focus and Highlights Benefits of Superoxide Dismutase Supplements
WELLINGTON, FL / ACCESSWIRE / November 14, 2024 / Cellev8 Nutrition Inc (OTC PINK:CELV), formerly known as Preferred Commerce, today issued a statement to clarify its business focus and retract ...
PharmiWeb1h
Nitches Inc. Announces InTheZone Labs' Launch on ShareASale, One of the World’s Leading Affiliate Networks
Nitches Inc. (OTC PINK:NICH) proudly announces a significant milestone in its journey toward nationwide expansion: InTheZone Labs, its premium supplement brand, is now live on ShareASale, one of the ...
PharmiWeb15h
MDaudit’s 2024 Benchmark Report Reveals a Fivefold…
Amid skyrocketing audit and denial rates, slower reimbursements, and lower dollars paid per claim, continuous risk monitoring will be crucial to financial stability in 2025. WELLESLEY, MA / ACCESSWIRE ...
PharmiWeb15h
Enalare Therapeutics is Granted a New Patent for ENA-001, Extending Its Exclusivity in the U.S. to 2043
<p><i>The New Patent Covers ENA-001 Methods of Treating Respiratory Depression Caused by Propofol, a Widely Used, Centrally Acting Anesthetic</i></p> PRINCETON, N.J., November 14, 2024 (Newswire.com) ...
PharmiWeb2h
IGC Pharma Reports Second Quarter Fiscal 2025 Results, Showcasing Progress in Its Alzheimer’s Pipeline
POTOMAC, MD / ACCESSWIRE / November 14, 2024 / IGC Pharma, Inc. ("IGC" or the "Company") (NYSE American:IGC) today announced its financial results and strategic advancements for the second fiscal ...
PharmiWeb2h
Zane Networks Awarded Blanket Purchase Agreement for Health and Human Services' Health IT Alignment Initiative
WASHINGTON, DC / ACCESSWIRE / November 14, 2024 / Zane Networks, LLC, a leader in healthcare transformation services and solutions, has been awarded a Blanket Purchase Agreement (BPA) by the Office of ...
PharmiWeb1h
Lexaria Signs Contract For New DehydraTECH GLP-1 Biodistribution Study
KELOWNA, BRITISH COLUMBIA / ACCESSWIRE / November 14, 2024 / Lexaria Bioscience Corp. (NASDAQ:LEXX)(NASDAQ:LEXXW) (the "Company" or "Lexaria"), a global innovator in drug delivery platforms, announces ...
PharmiWeb2h
Marinomed Biotech AG announces unanimous approval of the restructuring plan by creditors
InsolvencyMarinomed Biotech AG announces unanimous approval of the restructuring plan by creditors 14-Nov-2024 / 14:34 CET/CESTDisclosure of an inside information acc. to Article 17 MAR of the ...